The statistic depicts the distribution of the drug production value of central nervous system agents in Japan in 2016, broken down by sub therapeutic category. In 2016, the production value of psychotropics accounted for the largest share with about 27.1 percent of the total production, followed by antipyretics and analgesics, anti-inflammatory agents.
Drug production value share of central nervous system agents Japan 2016, by category
Distribution of the drug production value of central nervous system agents in Japan in 2016, by sub therapeutic category
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Drug production value central nervous system agents Japan 2016, by category
- Italy: psychoactive drug use among male teenagers 2016, by age
- Number of new psychoactive substance identified globally 2014
- Drug production value of allergic agents Japan 2016, by category
- Sales volume of the largest-selling prescription drugs in Spain 2015
- US adults impression of the US pharma industry by ethnicity 2017
- Sales value of the largest-selling prescription drugs sold in pharmacies Spain 2015
- US adults impression of the US pharma industry by age 2017
- U.S. adults impression of the U.S. pharma companies diversity of products
- US adults that believe physicians are pressured to prescribe drugs, by ethnicity
- Drug production value share of antineoplastics Japan 2016, by category
- U.S. adults impression of the U.S. pharma companies availability of their products
- Drug production value of cardiovascular agents Japan 2016, by category
- US adults that believe physicians are pressured to prescribe certain drugs, by age
- US adults impression of the US pharma industry by gender 2017
- U.S. adults impression of the U.S. pharma companies transparency
- US adults' rating of impact of patients/consumers on U.S. pharma by gender 2017
- US adults' rating of impact of politics on U.S. pharma industry by gender 2017
- US adults on research results impact on U.S. pharma industry by gender 2017
Further related statistics
MHLW (Japan). (September 20, 2018). Distribution of the drug production value of central nervous system agents in Japan in 2016, by sub therapeutic category [Graph]. In Statista. Retrieved December 11, 2019, from https://www.statista.com/statistics/738504/drug-production-value-share-of-central-nervous-system-agents-by-category-japan/
MHLW (Japan). "Distribution of the drug production value of central nervous system agents in Japan in 2016, by sub therapeutic category." Chart. September 20, 2018. Statista. Accessed December 11, 2019. https://www.statista.com/statistics/738504/drug-production-value-share-of-central-nervous-system-agents-by-category-japan/
MHLW (Japan). (2018). Distribution of the drug production value of central nervous system agents in Japan in 2016, by sub therapeutic category. Statista. Statista Inc.. Accessed: December 11, 2019. https://www.statista.com/statistics/738504/drug-production-value-share-of-central-nervous-system-agents-by-category-japan/
MHLW (Japan). "Distribution of The Drug Production Value of Central Nervous System Agents in Japan in 2016, by Sub Therapeutic Category." Statista, Statista Inc., 20 Sep 2018, https://www.statista.com/statistics/738504/drug-production-value-share-of-central-nervous-system-agents-by-category-japan/
MHLW (Japan), Distribution of the drug production value of central nervous system agents in Japan in 2016, by sub therapeutic category Statista, https://www.statista.com/statistics/738504/drug-production-value-share-of-central-nervous-system-agents-by-category-japan/ (last visited December 11, 2019)